Virbac SA Financials
| VIRP Stock | EUR 324.50 4.00 1.22% |
Virbac |
Understanding current and past Virbac SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Virbac SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Virbac SA's assets may result in an increase in income on the income statement.
Please note, the presentation of Virbac SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Virbac SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Virbac SA's management manipulating its earnings.
Virbac SA Stock Summary
Virbac SA competes with Bonduelle SCA, Biomerieux, Guerbet S, and Socit BIC. Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. Virbac SA was founded in 1968 and is headquartered in Carros, France. VIRBAC operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 4893 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0000031577 |
| Business Address | 13e rue LID |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | corporate.virbac.com |
| Phone | 33 4 92 08 71 00 |
| Currency | EUR - Euro |
You should never invest in Virbac SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Virbac Stock, because this is throwing your money away. Analyzing the key information contained in Virbac SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Virbac SA Key Financial Ratios
Virbac SA's financial ratios allow both analysts and investors to convert raw data from Virbac SA's financial statements into concise, actionable information that can be used to evaluate the performance of Virbac SA over time and compare it to other companies across industries.| Return On Equity | 0.15 | |||
| Return On Asset | 0.091 | |||
| Target Price | 311.6 | |||
| Beta | 0.88 | |||
| Last Dividend Paid | 1.25 |
Virbac Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Virbac SA's current stock value. Our valuation model uses many indicators to compare Virbac SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Virbac SA competition to find correlations between indicators driving Virbac SA's intrinsic value. More Info.Virbac SA is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Virbac SA is roughly 1.69 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Virbac SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Virbac SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Virbac SA Systematic Risk
Virbac SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Virbac SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Virbac SA correlated with the market. If Beta is less than 0 Virbac SA generally moves in the opposite direction as compared to the market. If Virbac SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Virbac SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Virbac SA is generally in the same direction as the market. If Beta > 1 Virbac SA moves generally in the same direction as, but more than the movement of the benchmark.
Virbac SA November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Virbac SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Virbac SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Virbac SA based on widely used predictive technical indicators. In general, we focus on analyzing Virbac Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Virbac SA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 20.63 | |||
| Value At Risk | (2.35) | |||
| Potential Upside | 3.03 |
Complementary Tools for Virbac Stock analysis
When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |